The association between MEF2A (Myocyte Enhancer Factor 2A) and Coronary Artery Disease, Autosomal Dominant, 1 is well established and manually curated, with its 3 contributing sources — 2 of them expert-curated — recording a known molecular basis, pathogenic variants, and a susceptibility locus.
Sources3
Clinical variants8
Symptoms18
Compounds0
Trials0
Publications4
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.